Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents
July 1, 2019
In this study, The RETeval device was be used as a tool to track the trauma level associated with anti-VEGF injections in both the infected eye and the non-injected eye. This study also highlights the capability of our device to help the physician check if the real effect of injections during a 1-month period of time as Previous work has shown on the month time scale an improved flicker implicit time indicating the anti-VEGF injections improve retinal function at this longer time scale.
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Substance Tables:
The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing.